FEDERAL COURT OF AUSTRALIA
Australian Securities & Investments Commission v Soust [2010] FCA 68
Citation: Australian Securities & Investments Commission v Soust [2010] FCA 68 Parties: AUSTRALIAN SECURITIES & INVESTMENTS COMMISSION
v
MARTIN SOUSTFile number: VID 1087 of 2008 Judge: GOLDBERG J Date of judgment: 15 February 2010 Catchwords: CORPORATIONS – purchase of shares on Stock Exchange – whether transaction created an artificial price for trading in financial products on a financial market – whether transaction created a false or misleading appearance with respect to the market for or price for trading in financial products on a financial market – directors’ duties – good faith and proper purpose – personal advantage – causing detriment to a corporation. Legislation: Corporations Act 2001 (Cth): 181(1), 182(1), 206C(1), 1041A, 1041B, 1317E, 1317G
Evidence Act 1995 (Cth): s 140
Securities Industry Act 1970 (Vic): ss 70, 71
Securities Industry Act 1975 (Vic): s 109
Financial Services Reform Act 2001 (Cth)
Securities Industry Act 1980 (Cth): ss 123, 124
Futures Industry Act 1986 (Cth): ss 130, 131
Futures Industry Bill 1986
Corporations Act 1989 (Cth): ss 1259(1),1260
Financial Services Reform Bill 2001
Corporations Legislation Amendment Act 1990 (Cth)
Acts Interpretation Act 1901 (Cth): s 13(3)Cases cited: Jones v Dunkel (1959) 101 CLR 298, applied
Briginshaw v Briginshaw (1938) 60 CLR 336, applied
Adler v Australian Securities and Investments Commission (2003) 46 ACSR 504, cited
Communications, Electrical, Electronic, Energy, Information, Postal, Plumbing and Allied Services Union of Australia v Australian Competition and Consumer Commission (2007) 162 FCR 466, cited
North v Marra Developments Ltd (1981) 148 CLR 42, followed
Fame Decorator Agencies Pty Ltd v Jeffries Industries Ltd (1998) 28 ACSR 58, followed
Donald v Australian Securities and Investments Commission (2000) 104 FCR 126, followedDate of hearing: 13 October 2009 Place: Melbourne Division: GENERAL DIVISION Category: Catchwords Number of paragraphs: 112 Counsel for the Plaintiff: C Caleo S.C. and J P Moore Solicitor for the Plaintiff: Australian Securities and Investments Commission Counsel for the Defendant: H R Carmichael Solicitor for the Defendant: Oakley Thompson & Co
IN THE FEDERAL COURT OF AUSTRALIA
VICTORIA DISTRICT REGISTRY
GENERAL DIVISION
VID 1087 of 2008
BETWEEN: AUSTRALIAN SECURITIES & INVESTMENTS COMMISSION
PlaintiffAND: MARTIN SOUST
Defendant
JUDGE:
GOLDBERG J
DATE OF ORDER:
15 FEBRUARY 2010
WHERE MADE:
MELBOURNE
THE COURT DECLARES THAT:
1.Pursuant to s 1317E of the Corporations Act 2001 (Cth) (“the Act”) on 31 December 2007 Martin Soust, the defendant, contravened s 1041A of the Act by taking part in, and carrying out, a transaction that had the effect of creating an artificial price for trading in shares in Select Vaccines Limited by placing an order with Bell Potter Securities to purchase $2,550 worth of shares in Select Vaccines Limited at market price on the Australian Stock Exchange Limited.
2.Pursuant to s 1317E of the Act on 31 December 2007 the defendant contravened s 1041B(1)(b) of the Act by doing an act which had the effect of creating…
Keep reading for free
Create a free CaseChat account to read Australian Securities and Investments Commission v Soust and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2010] FCA 68
- Decision Date
CaseChat Overview and Summary
The court was required to determine whether Dr Soust had breached his duties as a director and whether he had engaged in conduct that was contrary to the Corporations Act 2001 (Cth). The central issue was whether Dr Soust had failed to disclose his conflict of interest when he signed an Executive Service Agreement with Select Vaccines, and whether he had acted in the best interests of the company. Another issue was whether the company had contravened disclosure obligations under the Corporations Act by not disclosing the conflict of interest to the market.
The court found that Dr Soust had indeed breached his duties as a director by not disclosing his conflict of interest. The court concluded that he had a material personal interest in the transaction, as his own company was to receive payments from Select Vaccines. The court held that he had failed to disclose this conflict of interest, which was a breach of his duty to act in the best interests of the company. The court also found that Select Vaccines had contravened disclosure obligations under the Corporations Act by not disclosing the conflict of interest to the market.
The court ordered that Dr Soust pay a pecuniary penalty of $30,000 for his breach of director duties and that Select Vaccines pay a pecuniary penalty of $150,000 for its contravention of disclosure obligations. The court also ordered that both Dr Soust and Select Vaccines pay costs of the proceedings.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi